Skip to main content
Search
Search
Anywhere
Quick Search anywhere
Enter words / phrases / DOI / ISBN / keywords / authors / etc
Search
Advanced Search
Login
Skip main navigation
Open Drawer Menu
Close Drawer Menu
Home
Journal of Comparative Effectiveness Research
Journal of Patient Centricity
The Evidence Base
Skip slideshow
Journal of Comparative Effectiveness Research
ISSN (print): 2042-6305 • ISSN (online): 2042-6313
Impact Factor: 2.8 (2025) • CiteScore: 4.2 (2025) • Open Access
Read more
Journal of Patient Centricity
ISSN (online): 2978-8579
In partnership with the PCSIG • Open Access
Read more
The Evidence Base
Latest news, opinion and insight into hot topics including RWE, HEOR, HTA and market access
Read more
Latest
Cost-effectiveness analysis of ribociclib plus an aromatase inhibitor versus abemaciclib plus endocrine therapy in the adjuvant treatment of HR+/HER2- early breast cancer: a Canadian payer perspective
Dina Soliman
,
Christine Brezden-Masley
,
Sandeep Sehdev
,
Natalia Sabater-Anaya
, and
Talitha Vincken
Journal of Comparative Effectiveness Research
10 Nov 2026
Expert panel agreement with large language model responses to uro-oncology guideline-based questions: insights from seven Delphi consensus panels across major urological cancers
Ángel Borque-Fernando
,
Denis Navarro
,
Luis M Esteban
,
Daniel Pérez-Fentes
,
José Luis Álvarez-Ossorio
,
Carmen González Enguita
, and
Manuel Doblaré
Journal of Comparative Effectiveness Research
4 Nov 2026
NICE publishes methods framework for AI use in evidence generation and assessment
The Evidence Base
10 Nov 2026
ISPOR Europe 2026 – Inside the second plenary: Launching the pathway, not the product
The Evidence Base
10 Nov 2026
Journal of Comparative Effectiveness Research
Open access, peer-reviewed journal offering rapid publication for all aspects of HEOR and related areas
Read More
FROM THE EVIDENCE BASE
10 Nov 2026
ISPOR Europe 2026 daily round-ups: Insights from Day 2
9 Nov 2026
ISPOR Europe 2026 – Inside the first plenary: Beyond proving value – rethinking disease and redesigning healthcare
9 Nov 2026
ISPOR Europe 2026 daily round-ups: Insights from Day 1
10 Nov 2026
NICE publishes methods framework for AI use in evidence generation and assessment
10 Nov 2026
ISPOR Europe 2026 daily round-ups: Insights from Day 2
10 Nov 2026
NICE and NHS England test SMART as a shorter route into managed access for promising medicines
10 Nov 2026
ISPOR Europe 2026 daily round-ups: Insights from Day 2
9 Nov 2026
ISPOR Europe 2026 – Inside the first plenary: Beyond proving value – rethinking disease and redesigning healthcare
9 Nov 2026
ISPOR Europe 2026 daily round-ups: Insights from Day 1
The Evidence Base
Online hub providing the latest news, opinion and insights into HEOR, RWE, HTA and more
Read More
FROM THE EVIDENCE BASE
10 Nov 2026
NICE publishes methods framework for AI use in evidence generation and assessment
10 Nov 2026
ISPOR Europe 2026 – Inside the second plenary: Launching the pathway, not the product
10 Nov 2026
ISPOR Europe 2026 daily round-ups: Insights from Day 2
10 Nov 2026
NICE and NHS England test SMART as a shorter route into managed access for promising medicines
.png)
.png)
